Anticorps Recombinant de lapin anti-BCMA/TNFRSF17
BCMA/TNFRSF17 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
CoraLite®594 Fluorescent Dye
CloneNo.
241731A11
N° de cat : CL594-98215
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en cytométrie | U266 cells, |
Dilution recommandée
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
CL594-98215 cible BCMA/TNFRSF17 dans les applications de FC et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | BCMA/TNFRSF17 Protéine recombinante Eg1812 |
Nom complet | tumor necrosis factor receptor superfamily, member 17 |
Masse moléculaire calculée | 184 aa, 20 kDa |
Numéro d’acquisition GenBank | BC058291 |
Symbole du gène | TNFRSF17 |
Identification du gène (NCBI) | 608 |
Conjugaison | CoraLite®594 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 588 nm / 604 nm |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS with 0.09% sodium azide and 0.5% BSA |
Conditions de stockage | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Informations générales
BCMA (B cell maturation antigen), also known as TNFRSF17, is 20.2-kDa type III transmembrane glycoprotein and is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes and plasma cells, which may be important for B cell development and autoimmune response (PMID: 32943087; 9846698). BCMA has two agonist ligands: a proliferation-inducing ligand (APRIL) and BAFF. When BCMA binds to APRIL, it transmits signals of cell survival and proliferation (PMID: 27127303); when BCMA binds to BAFF, it mediates the activation of NF-kappaB and MAPK8/JNK (PMID: 36140254). It has been found that the overexpression and activation of BCMA are associated with multiple myeloma (MM) in preclinical models and humans, supporting its potential utility as a therapeutic target for MM (PMID: 32055000; 32943087).
Protocole
Product Specific Protocols | |
---|---|
FC protocol for CL594 BCMA/TNFRSF17 antibody CL594-98215 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |